Cboe Global Markets, Inc. · CBOE · FY2024 Q2 · Calendar Q3 2024

Cboe raises growth outlook as derivatives demand stays strong

The quarter supports a constructive operating thesis: strong derivatives demand, product expansion, international growth, and organic execution are supporting higher growth guidance. The evidence is positive, but the thesis depends on new-product adoption, a rebound in Data & Access Solutions timing, and regulatory execution.

Reported Before market openCBOEFinancial Services $35.55B market cap
100quality score

Earnings scorecard

Reported versus consensus
Reported EPS $2.15 Consensus $2.10
EPS surprise +2.4% Reported versus consensus
Reported revenue $974.0M Consensus $514.5M
Revenue surprise +89.3% Reported versus consensus

Market reaction

prior-close to event-session close
Stock move +4.3% Event window
SPY move -1.9% Same window
Abnormal move +6.2% Stock minus SPY
Volume 1.9× Versus trailing sessions
Subsequent drift +6.0% Up to 20 sessions
CBOESPY benchmark

Ask FN2 about CBOE FY2024 Q2

Transcript, numbers and history already loaded

Free account. Your question opens in FN2 with this report's transcript and numbers attached.

Transcript intelligence

What changed

Cboe reported record Q2 revenue and 21% EPS growth, raised full-year organic net revenue growth guidance to 6%-8%, and emphasized organic growth over M&A. New information included planned VIX futures options and variance futures launches, broader technology deployment, and additional international partnerships.

Guidance delta

Management raised full-year organic net revenue growth guidance from the prior quarter's higher end of 5%-7% range to 6%-8%.

Key takeaways

  • Q2 delivered record $514 million in net revenue, up 10% year over year, with adjusted EPS up 21% to $2.15.
  • Derivatives demand was strong, particularly in SPX index options and VIX products.
  • Data & Access Solutions growth slowed temporarily because of timing, while management expects a rebound.
  • Cboe is prioritizing organic initiatives over M&A and continuing capital returns.
  • International expansion and new volatility products are central to the next phase of growth.

Management priorities

  • Expand SPX, VIX and variance-futures products, subject to regulatory review.
  • Continue technology investment through dedicated cores and Cboe Global Cloud.
  • Grow international broker partnerships in APAC and Europe.
  • Maintain organic investment alongside share repurchases and dividends.

Follow CBOE with an agent that reads every filing, transcript, and price print. Free to start.

Try FN2 free

Earnings History

Estimate Beat Miss Match
CBOE REVENUE earnings history estimate and actual scatter chart 9 reported fiscal quarters and 3 future estimate-only quarters. Q4 '23 estimate $512M Q4 '23 actual $969M, beat Q1 '24 estimate $505M Q1 '24 actual $957M, beat Q2 '24 estimate $515M Q2 '24 actual $974M, beat Q3 '24 estimate $531M Q3 '24 actual $1B, beat Q2 '25 estimate $574M Q2 '25 actual $1B, beat Q3 '25 estimate $624M Q3 '25 actual $1B, beat Q4 '25 estimate $660M Q4 '25 actual $671M, beat Q1 '26 estimate $690M Q1 '26 actual $729M, beat Q2 '26 estimate $719M Q2 '26 actual $732M, beat Q3 '26 estimate $708M Q4 '26 estimate $705M Q1 '27 estimate $741M
Show less

Analyst Consensus ?

ConsensusHold31 ratings
Bullish1548.4%
Neutral1341.9%
Bearish39.7%

Analyst 52W Price Targets

$340.42Current
$97Low
$257.31Average
$450High

Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 25, 2026. Not an FN2 forecast.

Firm-level rating actions

FMP grade actions identify the grading firm, not a named analyst.

FirmRatingPrior ratingActionDate
Wells Fargo Equal Weight Equal WeightMaintainOct 14, 2026
TD Cowen Buy BuyMaintainOct 12, 2026
Morgan Stanley Overweight UnderweightUpgradeOct 9, 2026
Barclays Overweight OverweightMaintainOct 7, 2026
Goldman Sachs Neutral SellUpgradeOct 2, 2026
Show 26 more rating actions

Named analyst price targets

Upside is calculated against the persisted current price $340.42. FMP does not supply a rating on these named-analyst rows.

FirmAnalyst52W targetPrice when postedUpsideDate
Morgan StanleyAnalyst unavailable$450$327.72 +32.2%Oct 23, 2026
Wells FargoAnalyst unavailable$309$292.25 -9.2%Oct 14, 2026
Morgan StanleyMichael Cyprys$358$294.08 +5.2%Oct 9, 2026
Loop Capital MarketsAnalyst unavailable$343$278.2 +0.8%Oct 7, 2026
Loop Capital MarketsAnalyst unavailable$334$271.26 -1.9%Oct 5, 2026
See 78 more

Track every rating change on CBOE the moment it posts. Free to start.

Start free

Company context

Snapshot as of publication

Cboe Global Markets, Inc. functions as a global operator of various financial exchanges, primarily renowned for its options trading platforms, all managed through its numerous subsidiaries. The company organizes its expansive business activities into five distinct segments. The Options segment specializes in the trading of listed market indices. Its North American Equities division facilitates transactions for listed stocks in the United States and Canada, also offering services for exchange-traded products (ETPs), encompassing both trading and listing. The Futures segment is dedicated to futures trading.…

Historical context

All CBOE earnings

Financial Services peers this season

Latest reports in the same sector

Latest beats and misses

Who reports next

Get the CBOE recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Sources

  1. Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
  2. FN2 earnings calendar · 2024-10-17T05:10:49.140638+00:00
  3. Polygon adjusted daily market bars · 2026-10-24T23:00:43.019797+00:00
  4. Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-24T23:00:43.016908+00:00

Methodology

Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.

Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.

Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.

By FN2 Research · Updated · As of 2026-10-24. For educational purposes only; not investment advice.